Article Details
Retrieved on: 2021-06-24 12:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SEATTLE, June 24, 2021 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here